Track topics on Twitter Track topics that are important to you
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX:REPR) (“RMS Medical”) today announced the appointment of John Toomey to the newly created position of Vice President of Growth and Innovation. Mr. Toomey brings to RMS over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor.
Mr. Toomey will be responsible for research and development, product innovation, and business development, and integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform.
Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory and IP challenges in the medical device space.
Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.
Mr. Toomey holds 24 U.S. and foreign patents.
“Product innovation is a key driver of our previously announced strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets,” said Don Pettigrew, President and CEO of RMS Medical. “John has an impressive track record of developing and commercializing value-creating medical device solutions, and we are confident in his ability to help RMS pioneer new infusion products and applications. John is the latest in a series of strategic hires and appointments that we believe have positioned RMS Medical for continued growth and an elevated industry profile.”
“I am excited to join the team at RMS Medical at this important stage of development,” said Mr. Toomey. “The Company has a well-respected family of infusion therapy products, is addressing growing end markets, and is led by a seasoned and accomplished group of executives. I look forward to working with the team and building upon RMS Medical’s patient-focused platform.”
About RMS Medical Products
RMS Medical develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information about RMS Medical, please visit www.rmsmedicalproducts.com.
The statements contained herein include prospects, statements of future expectations and other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current views and assumptions and involve known and unknown risks and uncertainties, identified by words such as "believe." Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements. Factors that may cause actual results to differ materially from current expectations and other risks are discussed in RMS Medical’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K, which filings are available from the SEC and RMS Medical’s website. RMS Medical undertakes no obligation to update any forward-looking statements.
The Equity Group Inc.
Senior Vice President
Kalle Ahl, CFA
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...